What's Happening?
The Broadway musical 'Just In Time,' centered on the life of singer Bobby Darin, has successfully recouped its $12.5 million capitalization. This achievement marks it as the first Broadway musical of the 2024-2025 season to do so, joining only three other
productions this season. The musical, starring Jeremy Jordan, began its performances at the Circle in the Square Theatre on March 31, 2025, and officially opened on April 26, 2025. Despite a dip in grosses following the departure of initial lead Jonathan Groff, the show continues to perform well, recently grossing $838,055 for the week ending May 10. The production, developed and directed by Alex Timbers, features a book by Warren Leight and Isaac Oliver, and includes popular Darin hits like 'Beyond the Sea' and 'Mack the Knife.'
Why It's Important?
The financial success of 'Just In Time' is significant for the Broadway industry, demonstrating the enduring appeal of jukebox musicals and the potential for profitability even amidst fluctuating audience numbers. This success not only highlights the effective management and production strategies but also underscores the cultural resonance of Bobby Darin's music. The musical's ability to recoup its investment may encourage producers to invest in similar projects, potentially leading to a resurgence of interest in biographical musicals. Additionally, the planned North American tour in 2027 could further expand the show's reach and financial success, benefiting the broader theater community and local economies in tour locations.
What's Next?
Following its Broadway success, 'Just In Time' is set to embark on a North American tour starting in June 2027. While specific tour stops have been announced for next summer, additional locations are expected to be revealed early next year. The casting for the tour has yet to be announced, which could influence the show's reception in different markets. The tour presents an opportunity to reach new audiences and generate additional revenue, potentially setting a precedent for future Broadway productions to follow a similar model of extending their reach beyond New York.
